Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 10.3389/fphar.2016.00228 Pharmacology General Commentary Expression of Concern: Discoidin Domain Receptors: Potential Actors and Targets in Cancer Frontiers Editorial Office *

Edited and reviewed by: Théophile Godfraind, Université catholique de Louvain, Belgium

*Correspondence: Frontiers Editorial Office editorial.office@frontiersin.org

This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology

 21 07 2016 2016 7 228 14 07 2016 14 07 2016 Copyright © 2016 Frontiers Editorial Office. 2016 Frontiers Editorial Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 An expression of concern on Discoidin Domain Receptors: Potential Actors and Targets in Cancer by Rammal. H., Saby. C., Magnien. K., Van-Gulick. L., Garnotel, R., Buache, E., et al. (2016). Front. Pharmacol. 7:55. doi: 10.3389/fphar.2016.00055

With this notice, Frontiers states its awareness of concerns regarding a number of instances of failure to adequately cite or attribute credit appropriately within the above-referenced article. Prof. Theophile Godfraind and Prof. Olivier Feron, Chief Editors of the journal and specialty section respectively, will direct an investigation in full accordance with our procedures. The situation will be updated as soon as the investigation is complete.